[ET Net News Agency, 17 September 2025] Daiwa raised the target price for Sino Biopharm (01177) to HKD10 from HKD5.6 and maintained the "buy" rating.
The research house said it revises up 2025-27E revenue and EPS by 1-6% and 56-106%, respectively. (rc)
The research house said it revises up 2025-27E revenue and EPS by 1-6% and 56-106%, respectively. (rc)